Tilray Brands, Inc. - Common Stock (TLRY)
0.4500
-0.0258 (-5.42%)
NASDAQ · Last Trade: Apr 18th, 4:31 PM EDT
Detailed Quote
Previous Close | 0.4758 |
---|---|
Open | 0.4683 |
Bid | 0.4502 |
Ask | 0.4540 |
Day's Range | 0.4300 - 0.4838 |
52 Week Range | 0.4300 - 2.515 |
Volume | 44,272,484 |
Market Cap | 328.63M |
PE Ratio (TTM) | -0.4286 |
EPS (TTM) | -1.1 |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 27,133,863 |
Chart
About Tilray Brands, Inc. - Common Stock (TLRY)
Tilray Brands Inc is a global leader in the cannabis industry, specializing in the cultivation, production, and distribution of a diverse range of cannabis products. The company operates across various segments, including medical and recreational cannabis, as well as hemp-derived wellness products. Tilray focuses on innovation and quality, offering a portfolio that encompasses various formats such as dried flower, oils, edibles, and beverages. In addition to its core cannabis business, Tilray is dedicated to advancing research, education, and consumer awareness within the rapidly evolving market, positioning itself as a key player in the development and expansion of cannabis-related offerings worldwide. Read More
News & Press Releases
Cannabis news this week: Congress revives cannabis reform, Slovenia leads Europe, Tyson takes charge and science backs cannabis for cancer care.
Via Benzinga · April 18, 2025
Tilray shares are trading lower by 6.2% during Thursday's session. The company on Thursday announced plans to implement a reverse stock split.
Via Benzinga · April 17, 2025
Tilray shares fall 6.8% after announcing a proposed reverse stock split ahead of a June 10 shareholder vote.
Via Benzinga · April 17, 2025
Tilray Brands Inc. (NASDAQ: TLRY) has launched its first medical cannabis edibles in Australia through Tilray Medical. The new sugar-free, vegan Good Supply Pastilles offer THC and CBD options, enhancing patient access to plant-based therapies.
Via Benzinga · April 17, 2025
Keep it Cruisie: Enjoy a Taste of the No Frills, Good Life on The East End this Summer
By Tilray Brands, Inc. · Via GlobeNewswire · April 17, 2025
Tilray Medical Expands Offerings with Good Supply Brand Medical Cannabis Pastilles for Australian Patients
By Tilray Brands, Inc. · Via GlobeNewswire · April 17, 2025
NEW YORK and LEAMINGTON, Ontario, April 17, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of beverage, cannabis and wellness industries, today announced a special meeting of stockholders (the “Special Meeting”) on June 10, 2025. The Special Meeting will be held via live audio webcast, which can be accessed on the investor page on Tilray.com.
By Tilray Brands, Inc. · Via GlobeNewswire · April 17, 2025
Tilray Beverages Climbs to #4! Cheers to Ranking Among the Top Craft Brewers in the U.S.!
By Tilray Brands, Inc. · Via GlobeNewswire · April 16, 2025
Via The Motley Fool · April 16, 2025
The past, present and futur eof the Canasian cannabis sector.
Via Talk Markets · April 14, 2025
BEND, Ore., April 14, 2025 (GLOBE NEWSWIRE) -- 10 Barrel Brewing, a Tilray Brands, Inc., craft beer brand (NASDAQ: TLRY and TSX: TLRY), introduces Camp Coldie, 10 Barrel Brewing Co.’s highly-crushable new 5% IPA brewed in partnership with Scout Campers. Perfect for making a livin’ and doin’ the best you can, Camp Coldie was born a ramblin’ can!
By Tilray Brands, Inc. · Via GlobeNewswire · April 14, 2025
Via Talk Markets · April 12, 2025
Cannabis news of the week: Germany holds CanG, US delays, Chile bill; Italy hemp ban; SNDL expands, Tilray cuts outlook, US sales forecast –$21 B.
Via Benzinga · April 11, 2025
Via Benzinga · April 9, 2025
The past, present, and future of the Canadian cannabis sector.
Via Talk Markets · April 9, 2025
Shares of cannabis company Tilray Brands (NASDAQ:TLRY)
fell 19.7% in the afternoon session after the company reported weak fiscal third-quarter 2025 results that missed analysts' sales and EBITDA estimates, signaling ongoing challenges in growing its top line.
Via StockStory · April 8, 2025
Tilray Brands missed Q3 revenue expectations and lowered FY25 outlook, while beverage and wellness units posted year-over-year revenue increases.
Via Benzinga · April 8, 2025
Beer, wine, and spirits company Constellation Brands (NYSE:STZ)
will be reporting results tomorrow after market close. Here’s what you need to know.
Via StockStory · April 8, 2025